Patient-Reported Outcomes (Pros) With First-Line (1L) Cemiplimab In Patients With Locally Advanced Non-Small Cell Lung Cancer (Lansclc): EMPOWER-Lung 1 Subpopulation
| dc.contributor.author | Bondarenko, I. | |
| dc.contributor.author | Sezer, A. | |
| dc.contributor.author | Kilickap, S. | |
| dc.contributor.author | Gumus, M. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Gogishvili, M. | |
| dc.contributor.author | He, X. | |
| dc.contributor.author | Gullo, G. | |
| dc.contributor.author | Rietschel, P. | |
| dc.contributor.author | Quek, R. G. | |
| dc.date.accessioned | 2022-12-01T12:15:00Z | |
| dc.date.available | 2022-12-01T12:15:00Z | |
| dc.date.issued | 2022 | |
| dc.identifier.endpage | 85 | en_US |
| dc.identifier.issn | 0923-7534 | en_US |
| dc.identifier.startpage | 84 | en_US |
| dc.identifier.uri | https://reader.elsevier.com/reader/sd/pii/S0923753422002551?token=F81D614EB86BFF60216085822CE147E22A08EBDDCDE1049DF36DF115BD81C19835D4791709D44FF7BF0D47AEB4A5C1CB&originRegion=eu-west-1&originCreation=20221201121105 | |
| dc.identifier.uri | http://hdl.handle.net/11727/8196 | |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.wos | 000778453100114 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.1016/j.annonc.2022.02.139 | en_US |
| dc.relation.journal | ANNALS OF ONCOLOGY | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Patient-Reported Outcomes (Pros) With First-Line (1L) Cemiplimab In Patients With Locally Advanced Non-Small Cell Lung Cancer (Lansclc): EMPOWER-Lung 1 Subpopulation | en_US |
| dc.type | Conference Object | en_US |